Join our community of smart investors

Sanofi gets plant go-ahead

A regulatory untangle does little to boost Sanofi-Aventis's prospects
January 25, 2012

Franco-Swiss pharmaceuticals company Sanofi-Aventis has finally got the nod from the US drugs regulator for its new Framingham manufacturing facility, which forms part of its Genzyme acquisition.

IC TIP: Sell at 54€

The plant should start to relieve the production problems that have dogged Genzyme since before Sanofi acquired it.